Clinical trial

Effect of Red Blood Cell Survival on a Commonly Used Diabetes Lab Test-HbA1c

NCT01204216

Study summary

ClinicalTrials.gov

Effect of Red Blood Cell Survival on a Commonly Used Diabetes Lab Test-HbA1c

Design: INTERVENTIONAL · Status: TERMINATED · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

BIOLOGICAL · Unmapped registry intervention re-infusion of biotin labeled cells Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention Re-infusion of biotin labeled cells Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Diabetes education/diabetes medication adjustment Find medicine records · Find other trials using this name

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2010-09-01

PhaseNA

Conditions

Diabetes Mellitusverified · MONDO: diabetes mellitus

Impaired Fasting Glucoseunresolved

Prediabetesverified · MONDO: prediabetes syndrome

Interventions

re-infusion of biotin labeled cellsBIOLOGICAL

Re-infusion of biotin labeled cellsBIOLOGICAL

Diabetes education/diabetes medication adjustmentBEHAVIORAL

Sponsors & collaborators

VA Office of Research and Developmentlead sponsor

University of Cincinnaticollaborator

Mapped research locations

CincinnatiOhio, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01204216 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.